Reduction in Use of Risperidone for Dementia in Australia Following Changed Guidelines
Lisa M Kalisch Ellett, Anna K Moffat, Svetla Gadzhanova, Nicole L Pratt, Jemisha Apajee, Michael Woodward, Elizabeth E Roughead
Pharmacy | MDPI | Published : 2019
Awarded by NHMRC-ARC Dementia Research Development Fellowship
The research was funded by the Australian Government Department of Veterans' Affairs (DVA) as part of the delivery of the Veterans' Medicines Advice and Therapeutics Education Services (MATES) program. LMKE is supported by an NHMRC-ARC Dementia Research Development Fellowship (Grant identification number APP1101788). The contents of the published material are solely the responsibility of the individual authors and do not reflect the views of NHMRC.